DNA testing company Orchid to be acquired by LabCorp for $85M
Diagnostic technologies and genomic testing company LabCorp will buy DNA testing services company Orchid Cellmark in a deal valued at $85.4 million. LabCorp (NYSE:LH) said that the definitive agreement calls for the Burlington, North Carolina-based company to acquire all of the outstanding shares of Orchid (NASDAQ:ORCH) for $2.80 per share. That’s 39 percent more than […]